Publication:
Three monoclonal IgG components, an IgG4(Λ), an IgG2(κ) and an IgG1/IgG3 (κ) Gm(f,b) hybrid, in a single myeloma patient

dc.contributor.authorMilošević‐Jovčić, N. (6602090709)
dc.contributor.authorDovezenski, Nebojša (7801566450)
dc.contributor.authorJovanović, L. (57198361287)
dc.contributor.authorRolović, Z. (7006321033)
dc.contributor.authorGotić, M. (7004685432)
dc.contributor.authorRadošević, N. (6602961249)
dc.contributor.authorSuvajdžić, N. (7003417452)
dc.contributor.authorTošić, L. (6602381158)
dc.date.accessioned2025-06-12T11:53:10Z
dc.date.available2025-06-12T11:53:10Z
dc.date.issued1995
dc.description.abstractAbstract: An unusual triclonal IgG combination in the serum of a 56‐year old male with clinical stage IIIB multiple myeloma is reported. The patient initially had an IgG4(Λ) monoclonal protein in his serum and later developed an IgG2(κ) and an IgG (κ) which possessed the characteristics of both IgG1 and IgG3 subclasses with an unusual combination of allotypic markers. Three M‐proteins did not share idiotypic determinants. A rare class‐switch recombination followed by mutation has been considered as a possible mechanism leading to this combination. © Munksgaard 1995
dc.identifier.urihttps://doi.org/10.1111/j.1600-0609.1995.tb00688.x
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-0029005693&doi=10.1111%2fj.1600-0609.1995.tb00688.x&partnerID=40&md5=e1dfd59ae79e8e6c2462b650b9657cb3
dc.identifier.urihttps://remedy.med.bg.ac.rs/handle/123456789/1694
dc.subjectallotype
dc.subjecthybrid
dc.subjectidiotype
dc.subjectIgG
dc.subjectsubclass
dc.subjecttriclonal gammopathy
dc.titleThree monoclonal IgG components, an IgG4(Λ), an IgG2(κ) and an IgG1/IgG3 (κ) Gm(f,b) hybrid, in a single myeloma patient
dspace.entity.typePublication

Files